BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 16245771)

  • 1. [ASCOT-BPLA Study raises new questions regarding: which is the best initial antihypertensive drug?].
    MMW Fortschr Med; 2005 Sep; 147(39):12. PubMed ID: 16245771
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.
    Dahlöf B; Sever PS; Poulter NR; Wedel H; Beevers DG; Caulfield M; Collins R; Kjeldsen SE; Kristinsson A; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Ostergren J;
    Lancet; 2005 Sep 10-16; 366(9489):895-906. PubMed ID: 16154016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Old or new antihypertensives--which are better?].
    Schrader J; Kulschewski A
    MMW Fortschr Med; 2005 Mar; 147(13):36-7, 39-40. PubMed ID: 15832760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of the ASCOT-BPLA trial: no practical implications for treatment of hypertension.
    Prescrire Int; 2006 Jun; 15(83):112. PubMed ID: 16764103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fixed dose combination therapy in the treatment of hypertension.
    Stanton T; Reid JL
    J Hum Hypertens; 2002 Feb; 16(2):75-8. PubMed ID: 11850763
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hypertension therapies compared. Are the new nevertheless better than the old?].
    MMW Fortschr Med; 2005 Mar; 147(12):6, 8. PubMed ID: 15832780
    [No Abstract]   [Full Text] [Related]  

  • 7. [The combination of an ACE inhibitor and a calcium channel blocker is an optimal combination for the treatment of hypertension].
    Widimský J
    Vnitr Lek; 2009 Feb; 55(2):123-30. PubMed ID: 19348394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent intervention studies with antihypertensive drugs and their influence on guidelines].
    Rahn KH
    Med Klin (Munich); 2003 Dec; 98(12):771-5. PubMed ID: 14685679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinations of inhibitors of the renin-angiotensin system with calcium channel blockers for the treatment of hypertension: focus on perindopril/amlodipine.
    Mourad JJ; Le Jeune S; Pirollo A; Mourad C; Gaudouen Y; Lopez-Sublet M
    Curr Med Res Opin; 2010 Sep; 26(9):2263-76. PubMed ID: 20690889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [ALLHAT--the most comprehensive antihypertensive treatment trial in the world. The significance of thiazide diuretics for patients older than 55 years is confirmed].
    Nilsson P
    Lakartidningen; 2003 Feb; 100(6):400-4, 407. PubMed ID: 12607431
    [No Abstract]   [Full Text] [Related]  

  • 11. A rational approach to hypertension treatment in the older patient.
    Flack JM; Woolley A; Esunge P; Grimm RH
    Geriatrics; 1992 Nov; 47(11):24-8, 33-8. PubMed ID: 1358761
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comrades! There must be some blood order in the field of hypertension!].
    Melander A
    Lakartidningen; 2005 Apr 4-10; 102(14):1068-70. PubMed ID: 15892478
    [No Abstract]   [Full Text] [Related]  

  • 13. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function.
    Morimoto S; Maki K; Aota Y; Sakuma T; Iwasaka T
    Hypertens Res; 2008 Aug; 31(8):1603-10. PubMed ID: 18971536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypertension therapy in practice test. Calcium antagonist receives good marks].
    Keck M; Sauerbrey-Wullkopf N; Regourd E; Clemens A
    MMW Fortschr Med; 2005 Jan; 147(1-2):51. PubMed ID: 15704573
    [No Abstract]   [Full Text] [Related]  

  • 15. [Important points in selecting the first choice and combinations of various hypertensive agents].
    Takeda T; Kanayama Y
    Nihon Naika Gakkai Zasshi; 1990 Jan; 79(1):43-7. PubMed ID: 1969893
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison of preventive effect of "new" and "old" antihypertensive agents].
    Kjeldsen SE; Syvertsen JO; Lund-Johansen P; Hildebrandt P; Hansson L
    Tidsskr Nor Laegeforen; 2001 Apr; 121(11):1374-6. PubMed ID: 11419108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atorvastatin + amlodipine: new drug. Just a commercial ploy.
    Prescrire Int; 2007 Jun; 16(89):105. PubMed ID: 17582926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACE inhibitor-based, directly observed therapy for hypertension in hemodialysis patients.
    Zheng S; Nath V; Coyne DW
    Am J Nephrol; 2007; 27(5):522-9. PubMed ID: 17700014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Consequences of ALLHAT: Thiazides rehabilitated--time to change prescription patterns].
    Hernborg A; Håkansson J; Werkö L; Berglund G
    Lakartidningen; 2003 Feb; 100(6):408-10. PubMed ID: 12607432
    [No Abstract]   [Full Text] [Related]  

  • 20. [Calcium antagonists: current and future applications based on new evidence. Combination antihypertensive therapy with calcium channel blockers].
    Ishimitsu T
    Clin Calcium; 2010 Jan; 20(1):52-60. PubMed ID: 20048434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.